Advertisement

Topics

OncoVista Innovative Therapies, Inc. Company Profile

17:10 EDT 21st September 2017 | BioPortfolio

Texas-based OncoVista Innovative Therapies, Inc. (OTCBB: OVIT) is a high-growth theragnostic (the fusion of therapeutic and diagnostic medicine for individual patients) company that identifies specific biomarkers in the bloodstream carried by CTC’s to detect metastatic tumors. This allows an oncologist the unique ability to develop personalized, efficacious cancer treatments.


News Articles [651 Associated News Articles listed on BioPortfolio]

Innovative therapies require innovative thinking on access and cost

Americans should have affordable access to innovative, disease-altering therapies. Achieving that will require innovative approaches.

Shire: Innovative Therapies for Rare Diseases

SOURCE: Shire Pharmaceuticals DESCRIPTION:Shire is the global leader in serving patients with rare diseases. We strive to develop innovative therapies across a core of rare disease areas, supplemented...

Two New Italian €500m Funds for Innovative Drugs for Cancer, Hep C

New medicines for hepatitis C and cancer are among innovative therapies benefiting from two special funds set up by the...   

Injured bones reconstructed by gene and stem cell therapies

A Cedars-Sinai-led team of investigators has successfully repaired severe limb fractures in laboratory animals with an innovative technique that cues bone to regrow its own tissue. If found to be safe...

Bioverativ, Bicycle Therapeutics to develop therapies for hemophilia and sickle cell disease

Bioverativ and Bicycle Therapeutics have announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell disease.

Roivant Sciences Launches Urovant to Create Innovative Urology Therapies

NewsUrovant's lead therapeutic candidate is vibegron.Topics: 

STAT Plus: Personalized cancer therapies show great promise. The hitch? Manufacturing them efficiently

Experimental CAR-T therapies work well in blood cancers. The challenge for startups: Cranking out the personalized therapies at scale for patients worldwide.

Daiichi Sankyo and MD Anderson Collaborate to Accelerate Development of Acute Myeloid Leukemia Therapies

HOUSTON and TOKYO and BASKING RIDGE, N.J., Sept. 14, 2017 /PRNewswire/ — The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today a...

PubMed Articles [1071 Associated PubMed Articles listed on BioPortfolio]

Where biomedicalisation and magic meet: Therapeutic innovations of elite sports injury in British professional football and cycling.

Injury is a conspicuous feature of the practice and public spectacle of contemporary elite sports. The paper argues that the 'biomedicalisation' thesis (medico-industrial nexus, techno-scientific driv...

Innovating cystic fibrosis clinical trial designs in an era of successful standard of care therapies.

Evolving cystic fibrosis 'standards of care' have influenced recent cystic fibrosis clinical trial designs for new therapies; care additions/improvements will require innovative trial designs to maxim...

Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.

High attrition rates and loss of capital plague the drug discovery process. This is particularly evident for mitochondrial disease that typically involves neurological manifestations and is caused by ...

Energy metabolism in skin cancers: A therapeutic perspective.

Skin cancers are the most common cancers worldwide. The incidence of common skin cancers, including basal cell carcinomas (BCCs), squamous cell carcinoma (SCC) and melanomas, continues to rise by 5 to...

Mind-Body Therapies in Cancer: What Is the Latest Evidence?

Many people living with cancer use complementary therapies, and some of the most popular are mind-body therapies (MBTs), including relaxation and imagery, hypnosis, yoga, meditation, tai chi and qigon...

Clinical Trials [1786 Associated Clinical Trials listed on BioPortfolio]

Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases

Fatigue is common and disabling for most patients with inflammatory rheumatic disease. Therapies designed to improve physical activity and 'talking' treatments, which positively help patie...

Effect of Complementary and Alternative Medicine on Pain Among Inpatients

The proposed study has 3 aims: 1) quantitatively describe a model for delivering complementary and alternative medicine (CAM) therapies to understand the selection of patients and CAM ther...

Evaluation of an Innovative Tuberculosis Diagnostic Test

Diagnosis of tuberculosis (TB)in young children is a challenge due to atypical non-specific symptoms, difficulty to expectorate mucus, paucibacillary nature of pulmonary TB and low sensiti...

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Background: Patients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despite surgery. Circu...

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)

The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for wh...

Companies [1045 Associated Companies listed on BioPortfolio]

OncoVista Innovative Therapies, Inc.

Texas-based OncoVista Innovative Therapies, Inc. (OTCBB: OVIT) is a high-growth theragnostic (the fusion of therapeutic and diagnostic medicine for individual patients) company th...

OncoVista,inc.

OncoVista is aprivately held development-stage Pharmaceutical company dedicated to providing innovative,safe and efficacious treatments for cancer and other life threatening diseases.The combination ...

PDL BioPharma

PDL BioPharma is a leader in the discovery, development and marketing of innovative therapies for serious or life-threatening illnesses, commercially focused on the acute care, hospital setting. Our t...

Biogen and Sobi

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare ...

Biogen Inc.

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hema...

More Information about "OncoVista Innovative Therapies, Inc." on BioPortfolio

We have published hundreds of OncoVista Innovative Therapies, Inc. news stories on BioPortfolio along with dozens of OncoVista Innovative Therapies, Inc. Clinical Trials and PubMed Articles about OncoVista Innovative Therapies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OncoVista Innovative Therapies, Inc. Companies in our database. You can also find out about relevant OncoVista Innovative Therapies, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record